# European Study in Bone Sarcoma Patients Over 40 Years

> **NCT02986503** · — · COMPLETED · sponsor: **Italian Sarcoma Group** · enrollment: 100 (actual)

## Conditions studied

- Spindle Cell Sarcoma of Bone
- Osteosarcoma

## Interventions

- **DRUG:** Doxorubicin+cisplatin+ifosfamide
- **DRUG:** Doxorubicin+cisplatin+ifosfamide+methotrexate

## Key facts

- **NCT ID:** NCT02986503
- **Lead sponsor:** Italian Sarcoma Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2015-12
- **Final completion:** 2016-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-12-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02986503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02986503, "European Study in Bone Sarcoma Patients Over 40 Years". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02986503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*